Search
01/12/2024
Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma
Camacho, M, Vazquez-López, C, Valero, C, Holgado, A, Terra, X, Avilés-Jurado, FX, León, X. Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2024; 281(12)DOI:10.1007/s00405-024-08882-9. PMID:39215860. IF:2.200(Q1/3D).
01/12/2024
Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation
Redondo, S, Garcia-Cadenas, I, Esquirol, A, Portos, JM, Iranzo, E, Arguello-Tomas, M, Saavedra, S, Oñate, G, Caballero, AC, Garrido, A, López, J, Muntañola, A, Paviglianiti, A, Miqueleiz, S, Sierra, J, Briones, J, Martino, R. Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY. 2024; 113(6)DOI:10.1111/ejh.14294. PMID:39155459. IF:2.300(Q2/5D).
01/12/2024
Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene
van Kleef, ESB, Bouman, K, Molenaar, JPF, Küsters, B, Groothuis, JT, Olivé, M, Malfatti, E, Kamsteeg, EJ, Van Engelen, BGM, Ottenheijm, CAC, Doorduin, J, Voermans, NC. Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene. Neurology-Genetics. 2024; 10(6)DOI:10.1212/NXG.0000000000200214. PMID:39651462. IF:3.700(Q1/3D).
01/12/2024
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups
Vives, S, Quintela, D, Morgades, M, Cano-Ferri, I, Serrano, A, Acuña-Cruz, E, Cervera, M, Díaz-Beyá, M, Vidriales, B, Raposo-Puglia, JA, Arnan, M, Garrido, A, Balerdi, A, Cabello, AI, Herrera-Puente, P, Serrano, J, Coll, R, Tormo, M, López-Marín, J, García-Avila, S, Casado, MS, Padilla, I, Rodríguez-Macías, G, Calbacho, M, Puchol, A, Hernández, A, Torres, M, Costilla, L, Colorado, MM, Martínez-Cuadrón, D, Esteve, J, Montesinos, P. Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups. Cancers. 2024; 16(23)DOI:10.3390/cancers16234028. PMID:39682214. IF:4.400(Q2/3D).